Health management platform Redi.Health partners with Labcorp


Redi will give LabCorp a new ability to connect with patients with communication channels and tools

Redi.Health was founded with the aim of helping patients manage their health: the company builds specific tools for patients with multiple chronic diseases, which it then combines with more specialized support services thanks to partnerships with various players in the health sector, in particular specialized pharmacies, manufacturers of pharmaceutical products or insurance companies.

On Tuesday, Redi announced its latest partnership: Labcorp Drug Development, the clinical laboratory network’s contract research organization.

Going forward, Redi’s digital assistance platform will be integrated with Labcorp Drug Development’s patient access solutions to provide patients and their care providers with communication channels and tools, with the goal of help them better manage patient health.

“Labcorp is one of the best patient support service providers in the country, and connecting with them and very quickly securing a strategic partnership agreement to bring a truly new solution to market, is something that speaks to what we do, why it matters and how it can have an impact,” Luke Buchanan, co-founder and CEO of Redi.Health, said in an interview.

Through this partnership, Redi will give Labcorp a new ability to connect with patients, while Labcorp gives Redi a better way to reach pharmaceutical manufacturers to connect with their patients, he explained.

For example, a pharmaceutical customer may come to LabCorp because they want to distribute different resources and services, such as the ability to talk to nurse counsellors, access financial assistance, and access different educational resources about the medications they take. Today, thanks to this partnership, Redi would be a new distribution channel for these services.

“Often in today’s space, LabCorp would do this outreach via email or mail, maybe a one-way text message, and definitely a phone call. It works for a lot of patients in the space. today, but there is no truly robust numerical method in which all can be distributed,” Buchanan said.

“LabCorp is absolutely unmatched when it comes to real patient outreach, ensuring the quality of support provided to patients on behalf of pharmaceutical manufacturers is the highest factor. And what Redi can do is simply expand the applicability to patients when we have this partnership,” Buchanan said.

“The value that LabCorp already provides to its pharmaceutical manufacturing partners, Redi can step in and enhance further by providing a new digital pathway for LabCorp to then communicate with patients and providing patients with several different options that they can enter into. contact with the support they need for the medications they are taking.”

While Labcorp and other vendors may focus on a particular drug and provide as much support as possible around that drug for those pharmaceutical manufacturers, Redi instead serves one patient for all of their medications, conditions, diet, and exercise.

“Having that support provided by LabCorp, on behalf of the pharmaceutical manufacturers, alongside what a patient can use for any aspect of their health, just creates a better one-stop-shop for that patient to manage their health. health, and easier access to this support that is so needed for a complex area of ​​their health,” Buchanan said.

Founded in 2021, Columbus, Ohio-based Redi partners with healthcare players who get their patients to download the free Redi app, which brings together other elements of their healthcare, including exercise, diet tracking, medication tracking, and symptom tracking.

Once a patient downloads the app, they go through the registration process, which has only three steps and takes just one minute, requiring patients to answer questions about the medications they are taking, the conditions they have, and then some demographic information. . After that, the platform adapts to that patient, bringing them relevant articles and tools related to their specific disease states.

The ultimate goal is to increase patient engagement and, therefore, improve outcomes for all stakeholders in the healthcare ecosystem.

“Redi’s goals are to serve as many patients as the pharmaceutical industry serves today by providing that support, and LabCorp is a great way for us to do that in a way that’s a little more original to manufacturers.” , Buchanan said.

“Rather than having to cobble together a solution from different vendors, our partnership with LabCorp provides the opportunity for a pharmaceutical manufacturer to get this unique solution of traditional outreach and support methods, and our very robust digital outreach methods. and contemporary. and support, in a single solution and a single transaction.”

(Image source:


Comments are closed.